article

Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs.

Molecular Pharmacology · 1986 · Vol. 29(3) · pp. 307–313

Allyn C. Howlett✉J M QualyLeili Khachatrian

Pharmacological Receptor Mechanisms and Effects Neurotransmitter Receptor Influence on Behavior Cardiac electrophysiology and arrhythmiasAdenylate kinaseCyclasePertussis toxinBiochemistryChemistryADP-ribosylationNAD+ kinaseMechanism of actionG proteinPharmacology

MeSH terms

Adenylyl Cyclase InhibitorsCyclic AMPAdenosine Diphosphate RiboseAnimalsCannabinoidsCarbacholCells, CulturedGliomaHybrid CellsLymphomaManganeseMembrane ProteinsMorphineNADNeuroblastoma

Citations

463

FWCI

1.28

field-weighted impact

References

Percentile

79%

vs. same field & year

Citations per year

Cited by

Determination and characterization of a cannabinoid receptor in rat brain.

Molecular Pharmacology · 1988 · 2,412 citations

Cannabis: pharmacology and toxicology in animals and humans

Addiction · 1996 · 503 citations

Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures — A short review

Pharmacology Biochemistry and Behavior · 2008 · 455 citations

Endocannabinoids

European Journal of Pharmacology · 1998 · 428 citations

Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations

European Journal of Biochemistry · 1995 · 1,747 citations

Cannabinoid physiology and pharmacology: 30 years of progress

Neuropharmacology · 2004 · 605 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.